Paul McCall brings 13 years of experience in research and development and quality control in health authority-regulated environments to his role as PMI Bio’s director of quality assurance and analytical development.

Paul begin his career at Mylan Pharmaceuticals, performing method development, raw material characterization, drug product formulation characterization, method validation, and release and stability testing before joining Berg, LLC where he held a director level position leading analytical development. Paul has broad experience, including oversight of analytical development activities and direct involvement in submissions to and responses to questions posed by various health authorities (FDA, Health Canada, MHRA, PMDA, TGA, and EMA).

Part of the PMI Bio team since 2018, Paul earned a bachelor’s degree in chemistry from Western Carolina University and a doctorate degree in analytical chemistry from Florida State University.